Mortality (m), MR per 100 patient-years and mortality rate ratios after admission for AECOPD
| hs-cTnT pattern | MR ratio | |||
|---|---|---|---|---|
| Stable (n=12) | Dynamic (n=53) | |||
| Variable | m (MR) | m (MR) | Unadjusted | Adjusted |
| Age (years) | 2.5 | |||
| <65 | 0 | 5 (13) | 0 | |
| 65–75 | 3 (74) | 13 (35) | 2.1 | |
| >75 | 8 (141) | 11 (34) | 4.1 | |
| History of CAD | 2.9 | |||
| No | 7 (131) | 22 (23) | 5.7 | |
| Yes | 4 (91) | 7 (52) | 1.8 | |
| History of LVHF | 3.4 | |||
| No | 9 (133) | 26 (27) | 4.9 | |
| Yes | 2 (67) | 3 (28) | 2.4 | |
| NT-proBNP tertile | 3.4 | |||
| 1 (<283 pg/mL) | 0 | 5 (9,0) | 0 | |
| 2 (283–1181 pg/mL) | 4 (172) | 12 (38) | 4.5 | |
| 3 (≥1181 pg/mL) | 7 (136) | 12 (58) | 2.3 | |
| Low Hb* | 2.7 | |||
| No | 5 (120) | 23 (24) | 5.0 | |
| Yes | 6 (109) | 6 (49) | 2.2 | |
| Total | 11 (113) | 29 (27) | 4.2 | |
Stratified by potential confounders of the association between hs-cTnT pattern and mortality.
*Hb<13 in men and <12 in women.
AECOPD, acute exacerbation of chronic obstructive pulmonary disease; BNP, B-type natriuretic peptide; CAD, coronary artery disease; Hb, haemoglobin; LVHF, left ventricular heart failure; MR, mortality ratio.